<h4>Background</h4>Glucose-6-phosphate dehydrogenase (G6PD) deficiency is traditionally recognized as a risk factor for drug- or infection-induced hemolytic anemia. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.